Literature DB >> 23594919

Long-term statin administration to dams on high-fat diet protects not only them but also their offspring from cardiovascular risk.

M M Elahi1, F R Cagampang, S K Ohri, M A Hanson.   

Abstract

We aimed to study the effects of long-term statin administration to high fat (HF)-fed female mice from the time they were weaned through to pregnancy and lactation on cardiovascular and metabolic risk factors in their HF-fed offspring. Female C57 mice on HF (45% kcal fat) were given pravastatin in their drinking water from the time they were weaned, during pregnancy and lactation. Weaned offspring were then fed an HF diet until adulthood generating the dam/offspring dietary groups HF/HF and HF plus pravastatin from the time dams were weaned, during pregnancy and lactation/HF (HF+S/HF). These groups were compared with offspring from mothers fed standard chow (control) which were then fed a control diet up to adulthood (control/control; C/C). HF+S dams showed significantly reduced total cholesterol concentrations and systolic blood pressure (SBP) versus HF dams. The reduction in total cholesterol and SBP in the HF+S dams did not restore values to those observed in the C group. Both male and female HF+S/HF offspring were significantly lighter in weight, and had lower SBP and serum cholesterol concentrations versus HF/HF. HF/HF offspring had elevated C-reactive protein levels but HF+S/HF animals of both sexes had reduced levels similar to those found in the C/C group. Long-term pravastatin administration to dams not only protects them from the deleterious effects of an HF diet, but this long-term maternal statin protection also has an equal and permanent effect in both male and female offspring up to their adult life, which is a novel finding.
Copyright © 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23594919     DOI: 10.1159/000346037

Source DB:  PubMed          Journal:  Ann Nutr Metab        ISSN: 0250-6807            Impact factor:   3.374


  4 in total

Review 1.  Early developmental conditioning of later health and disease: physiology or pathophysiology?

Authors:  M A Hanson; P D Gluckman
Journal:  Physiol Rev       Date:  2014-10       Impact factor: 37.312

2.  Pravastatin to prevent recurrent fetal death in massive perivillous fibrin deposition of the placenta (MPFD).

Authors:  Tinnakorn Chaiworapongsa; Roberto Romero; Steven J Korzeniewski; Piya Chaemsaithong; Edgar Hernandez-Andrade; James H Segars; Alan H DeCherney; M Cathleen McCoy; Chong Jai Kim; Lami Yeo; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2015-04-20

Review 3.  Early-Life Origins of Metabolic Syndrome: Mechanisms and Preventive Aspects.

Authors:  Chien-Ning Hsu; Chih-Yao Hou; Wei-Hsuan Hsu; You-Lin Tain
Journal:  Int J Mol Sci       Date:  2021-11-02       Impact factor: 5.923

4.  Divergence of mechanistic pathways mediating cardiovascular aging and developmental programming of cardiovascular disease.

Authors:  Beth J Allison; Joepe J Kaandorp; Andrew D Kane; Emily J Camm; Ciara Lusby; Christine M Cross; Rhianon Nevin-Dolan; Avnesh S Thakor; Jan B Derks; Jane L Tarry-Adkins; Susan E Ozanne; Dino A Giussani
Journal:  FASEB J       Date:  2016-03-01       Impact factor: 5.191

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.